Lakewood-Amedex Biotherapeutics, Inc. (LABT)
2.22
+0.17
(+8.29%)
USD |
NASDAQ |
Sep 11, 16:00
2.15
-0.07
(-3.15%)
Pre-Market: 08:38
Lakewood-Amedex Biotherapeutics Market Cap : 4.816M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 4.816M |
| September 10, 2026 | 4.447M |
| September 09, 2026 | 5.032M |
| September 08, 2026 | 4.729M |
| September 04, 2026 | 4.078M |
| September 03, 2026 | 4.122M |
| September 02, 2026 | 4.490M |
| September 01, 2026 | 5.987M |
| August 31, 2026 | 5.423M |
| August 28, 2026 | 4.989M |
| August 27, 2026 | 5.401M |
| August 26, 2026 | 5.314M |
| August 25, 2026 | 4.968M |
| August 24, 2026 | 4.620M |
| August 21, 2026 | 4.859M |
| August 20, 2026 | 4.750M |
| August 19, 2026 | 4.859M |
| August 18, 2026 | 4.989M |
| August 17, 2026 | 4.686M |
| August 14, 2026 | 4.924M |
| August 13, 2026 | 5.054M |
| August 12, 2026 | 5.119M |
| August 11, 2026 | 1.662M |
| August 10, 2026 | 1.655M |
| August 07, 2026 | 1.564M |
| Date | Value |
|---|---|
| August 06, 2026 | 1.571M |
| August 05, 2026 | 1.627M |
| August 04, 2026 | 1.564M |
| August 03, 2026 | 1.521M |
| July 31, 2026 | 1.423M |
| July 30, 2026 | 1.359M |
| July 29, 2026 | 1.394M |
| July 28, 2026 | 1.479M |
| July 27, 2026 | 1.761M |
| July 24, 2026 | 1.859M |
| July 23, 2026 | 2.155M |
| July 22, 2026 | 2.402M |
| July 21, 2026 | 1.31M |
| July 20, 2026 | 1.359M |
| July 17, 2026 | 1.331M |
| July 16, 2026 | 1.303M |
| July 15, 2026 | 1.711M |
| July 14, 2026 | 1.796M |
| July 13, 2026 | 1.923M |
| July 10, 2026 | 1.838M |
| July 09, 2026 | 1.859M |
| July 08, 2026 | 1.676M |
| July 07, 2026 | 1.683M |
| July 06, 2026 | 1.930M |
| July 02, 2026 | 1.937M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.69B |
| Oncolytics Biotech, Inc. | 92.92M |
| Sangamo Therapeutics, Inc. | 61.52M |
| Sarepta Therapeutics, Inc. | 2.160B |
| Anixa Biosciences, Inc. | 95.45M |
Market Cap Related Metrics
| PEG Ratio | -0.0015 |
| Price to Book Value | 1.112 |
| Price | 2.22 |
| Earnings Yield | -465.7% |
| PEGY Ratio | -0.0015 |